AIxCrypto Holdings, Inc. (AIXC): Nasdaq/NYSE listing notice — Qualigen receives Nasdaq delisting notice but regains compliance with $4.5M preferred stock placement

AIxCrypto Holdings, Inc.

Received Nasdaq notice on July 23, 2025 for failing to meet $2.5M stockholders' equity requirement.
Closed $4.5M private placement of Series A-3 Preferred Stock to regain equity compliance.
Nasdaq granted extension; company's compliance plan accepted for next 12 months.
Company made timely filing of Q1 10-Q on July 21, 2025.
No assurance of continued listing; company remains at risk.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

July 24, 2025, the Company received a follow-up communication from the Office of the General Counsel of Nasdaq confirming that Nasdaq had granted the Company’s request for an extension to regain compliance. Nasdaq acknowledged that: The Company timely filed its Quarterly Report on Form 10-Q on or before the required deadline of July 21, 2025; The Company has demonstrated compliance with the Equity Rule on a pro forma basis following the closing of a $4.5 million private placement of Series A-3 Preferred Stock, before customary fees and expenses; and The Company submitted a compliance plan outl

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-021198

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.